Clinical Evaluation of the InflammaDry Device for Detecting Dry Eye
NCT01692964 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 237
Last updated 2020-10-12
Summary
InflammaDry is a rapid diagnostic test for the detection of elevated levels of Matrix Metalloproteinase-9 (MMP-9) protein in tear fluid.
Conditions
- Dysfunctional Tear Syndrome
Interventions
- DEVICE
-
InflammaDry
A noninvasive immunoassay for detecting MMP-9 levels in tears.
Sponsors & Collaborators
-
Rapid Pathogen Screening
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-10-31
- Primary Completion
- 2013-05-31
- Completion
- 2013-05-31
Countries
- United States
Study Locations
More Related Trials
-
TrueTear in Sjogren's Disease Patients
NCT03719885 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Performance and Safety of Eye Drops With Hydroxypropyl-methylcellulose and Inositol in Drye Eye Disease
NCT06190054 ·Status: RECRUITING ·Phase: NA
-
Study of Platelet Rich Plasma Drops to Moderate Clinically Significant Dry Eye
NCT05121493 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator
NCT02798289 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Rapid Screening Test for Detection of Adenovirus in Tears
NCT00266734 ·Status: COMPLETED ·Phase: NA
-
Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye
NCT02257957 ·Status: COMPLETED ·Phase: PHASE3
-
TearCare System to Treat Dry Eye Disease
NCT03857919 ·Status: COMPLETED ·Phase: NA
-
Multicenter Trial Evaluating Quality of Tears Produced by Nasal Neurostimulation
NCT02385292 ·Status: COMPLETED ·Phase: NA
-
Goblet Cell Degranulation Produced by Intranasal Tear Neurostimulator (ITN) in Dry Eye Disease
NCT03827564 ·Status: TERMINATED ·Phase: NA
-
Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface
NCT04198740 ·Status: RECRUITING
-
Differential Diagnosis of Sjögren's Versus Non-Sjögren's Dry Eye
NCT04493658 ·Status: COMPLETED
-
Assessment of Inflammatory and Functional Changes in the Ocular Surface Associated With Dry Eye Disease
NCT00809003 ·Status: COMPLETED
-
Intense Pulsed Light Study for Dry Eye Disease
NCT03089580 ·Status: COMPLETED ·Phase: NA
-
Normal Lacritin Levels in Human Tears- Development of a New Clinical Assay
NCT00487643 ·Status: COMPLETED
-
A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease
NCT04030962 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Non-invasive Tear Film Dynamic Measurements in Normal, MGD and ADDE Subjects After Saline Instillation
NCT01128049 ·Status: COMPLETED ·Phase: NA
-
Effects of NOV03 on the Tear Film
NCT05723770 ·Status: COMPLETED ·Phase: PHASE4
-
Topical Steroid Treatment For Dry Eye
NCT02218827 ·Status: UNKNOWN ·Phase: NA
-
Six Month Study to Evaluate the Safety and Effectiveness of the Intranasal Lacrimal Neurostimulator
NCT02526290 ·Status: COMPLETED ·Phase: NA
-
Metabolites of Tear Fluid
NCT03389282 ·Status: UNKNOWN
-
Closed Eye Neutrophils in Dry Eye Disease
NCT03332342 ·Status: COMPLETED ·Phase: NA
-
Treatment of Meibomian Gland Dysfunction and Dry Eye in Contact Lens Wearers
NCT02102464 ·Status: COMPLETED ·Phase: NA
-
Ocular Surface Immune Response in Dry Eye Disease
NCT02042820 ·Status: COMPLETED
-
Evaluation of Lacrimal Punctal Changes by Anterior Segment Optical Coherence Tomography AS-OCT After Topical Combined Antibiotics and Steroids Treatment in Cases of Inflammatory Punctual Stenosis
NCT05028907 ·Status: COMPLETED ·Phase: PHASE4
-
Dry Eye Symptom Relief Assessment With Use of TrueTear in a Controlled Adverse Environment
NCT03097614 ·Status: COMPLETED ·Phase: NA